litlas
Log inCreate account

Jane C. Davies

Active 1988–2025

Also published as
Jane C Davies
122
Papers
19,349
Citations
65
h-index
115
i10-index

Citations

Citations per year for Jane C. Davies1989: 3 citations1990: 1 citations1991: 1 citations1992: 3 citations1993: 2 citations1994: 4 citations1995: 2 citations1996: 1 citations1997: 2 citations1998: 3 citations1999: 5 citations2000: 15 citations2001: 12 citations2002: 11 citations2003: 7 citations2004: 14 citations2005: 14 citations2006: 9 citations2007: 7 citations2008: 21 citations2009: 33 citations2010: 48 citations2011: 63 citations2012: 92 citations2013: 136 citations2014: 138 citations2015: 139 citations2016: 199 citations2017: 193 citations2018: 199 citations2019: 765 citations2020: 894 citations2021: 915 citations2022: 747 citations2023: 654 citations2024: 911 citations2025: 390 citations2026: 5 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,682 citing papers, 24.1% of this breakdownUnited Kingdom: 827 citing papers, 11.9% of this breakdownGermany: 411 citing papers, 5.9% of this breakdownAustralia: 368 citing papers, 5.3% of this breakdownCanada: 368 citing papers, 5.3% of this breakdownItaly: 360 citing papers, 5.2% of this breakdownChina: 357 citing papers, 5.1% of this breakdownFrance: 304 citing papers, 4.4% of this breakdownNetherlands: 236 citing papers, 3.4% of this breakdownSwitzerland: 184 citing papers, 2.6% of this breakdownIreland: 154 citing papers, 2.2% of this breakdownBelgium: 143 citing papers, 2.1% of this breakdown
0%24.1%Other 22.5%

Institutions

Fields

  • Medicine60.5%
  • Biochemistry, Genetics and Molecular Biology26.7%
  • Immunology and Microbiology3.6%
  • Environmental Science2.2%
  • Engineering1.1%
  • Health Professions1.1%
  • Other4.8%

Topics

  • Cystic Fibrosis Research Advances15.4%
  • Neonatal Respiratory Health Research6.4%
  • Asthma and respiratory diseases5%
  • Gut microbiota and health4.2%
  • Pediatric health and respiratory diseases3.2%
  • Tracheal and airway disorders2.8%
  • Other63%

Coauthors

All papers

Open in search
  1. The future of cystic fibrosis care: a global perspective

    Authors: Scott C Bell, Marcus A Mall, Hector Gutierrez, Milan Macek, Susan Madge, Jane C Davies, Pierre-Régis Burgel, Elizabeth Tullis, Claudio Castaños, Carlo Castellani, Catherine A Byrnes, Fiona Cathcart, Sanjay H Chotirmall, Rebecca Cosgriff, Irmgard Eichler, Isabelle Fajac, Christopher H Goss, Pavel Drevinek, Philip M Farrell, Anna M Gravelle, Trudy Havermans, Nicole Mayer-Hamblett, Nataliya Kashirskaya, Eitan Kerem, Joseph L Mathew, Edward F McKone, Lutz Naehrlich, Samya Z Nasr, Gabriela R Oates, Ciaran O'Neill, Ulrike Pypops, Karen S Raraigh, Steven M Rowe, Kevin W Southern, Sheila Sivam, Anne L Stephenson, Marco Zampoli, Felix Ratjen - The Lancet Respiratory Medicine 2019 cited by 961

  2. Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane

    Authors: Akshay Sabnis, Katheryn LH Hagart, Anna Klöckner, Michele Becce, Lindsay E. Evans, R. Christopher D. Furniss, Despoina A. I. Mavridou, Ronan A. Murphy, Molly M. Stevens, Jane C. Davies, Gerald Larrouy‐Maumus, Thomas B. Clarke, Andrew M. Edwards - eLife 2021 cited by 391

  3. Cystic fibrosis

    Authors: Michal Shteinberg, Iram Haq, Deepika Polineni, Jane C. Davies - The Lancet 2021 cited by 651

  4. Disordered Microbial Communities in Asthmatic Airways

    Authors: Markus Hilty, Conor M. Burke, Helder Pedro, Paúl Cárdenas, Andy Bush, Cara Bossley, Jane C. Davies, Aaron Ervine, Len W. Poulter, Lior Pachter, Miriam F. Moffatt, William Cookson - PLoS ONE 2010 cited by 1,836

  5. A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation

    Authors: Bonnie W. Ramsey, Jane C. Davies, Noel G. McElvaney, Elizabeth Tullis, Scott C. Bell, Pavel Dřevínek, Matthias Griese, Edward F. McKone, Claire Wainwright, Michael W. Konstan, Richard B. Moss, Félix Ratjen, Isabelle Sermet‐Gaudelus, Steven M. Rowe, Qunming Dong, Sally Rodriguez, Karl Yen, Claudia L. Ordoñez, J.S. Elborn - New England Journal of Medicine 2011 cited by 2,174

  6. Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR

    Authors: Claire Wainwright, J.S. Elborn, Bonnie W. Ramsey, Gautham Marigowda, Xiaohong Huang, Marco Cipolli, Carla Colombo, Jane C. Davies, K. De Boeck, Patrick A. Flume, Michael W. Konstan, Susanna A. McColley, Karen McCoy, Edward F. McKone, À. Munck, Félix Ratjen, Steven M. Rowe, David Waltz, Michael Boyle - New England Journal of Medicine 2015 cited by 1,621

  7. A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele

    Authors: Edith T. Zemanick, Jennifer L. Taylor‐Cousar, Jane C. Davies, Ronald L. Gibson, Marcus Mall, Edward F. McKone, Paul McNally, Bonnie W. Ramsey, Jonathan H. Rayment, Steven M. Rowe, Elizabeth Tullis, Neil Ahluwalia, Chenghao Chu, Thang Ho, Samuel M. Moskowitz, Sabrina Noël, Simon Tian, David Waltz, Tanya G. Weinstock, Fengjuan Xuan, Claire Wainwright, Susanna A. McColley - American Journal of Respiratory and Critical Care Medicine 2021 cited by 288

  8. Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3b, Randomized, Placebo-controlled Study

    Authors: Marcus Mall, Rossa Brugha, Silvia Gärtner, Julian Legg, Alexander Mœller, Pedro Mondéjar-López, Dario Prais, Tacjana Pressler, Félix Ratjen, Philippe Reix, Paul D. Robinson, Hiran Selvadurai, Florian Stehling, Neil Ahluwalia, Emilio Arteaga‐Solis, Bote G. Bruinsma, Mark T. Jennings, Samuel M. Moskowitz, Sabrina Noël, Simon Tian, Tanya G. Weinstock, Pan Wu, Claire Wainwright, Jane C. Davies - American Journal of Respiratory and Critical Care Medicine 2022 cited by 140

  9. Future therapies for cystic fibrosis

    Authors: Lucy Allen, Lorna Allen, S.B. Carr, Gwyneth Davies, D.G. Downey, Marie E. Egan, Julian Forton, Robert D. Gray, Charles Haworth, Alex Horsley, Alan R Smyth, Kevin W Southern, Jane C. Davies - Nature Communications 2023 cited by 134

  10. Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis

    Authors: Steven M. Rowe, Cori Daines, Felix C. Ringshausen, Eitan Kerem, John Wilson, Elizabeth Tullis, Nitin Nair, C Simard, Linda K. Han, Edward P. Ingenito, Charlotte McKee, Julie Lekstrom-Himes, Jane C. Davies - New England Journal of Medicine 2017 cited by 511

  11. Improvement in Lung Clearance Index and Chest Computed Tomography Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older – The RECOVER Trial

    Authors: Paul McNally, Karen Lester, Gavin Stone, B. Elnazir, Michael Williamson, D. Cox, Barry Linnane, L. Kirwan, David Rea, Paul O’Regan, Tom Semple, Clare Saunders, Harm A.W.M. Tiddens, Edward F. McKone, Jane C. Davies - American Journal of Respiratory and Critical Care Medicine 2023 cited by 84

  12. Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged ≥6 Years with Cystic Fibrosis and at Least One F508del Allele: A Phase 3, Open-Label Clinical Trial

    Authors: Claire Wainwright, Susanna A. McColley, Paul McNally, Michael R. Powers, Félix Ratjen, Jonathan H. Rayment, George Retsch‐Bogart, Erica A. Roesch, Neil Ahluwalia, Anna Chin, Chenghao Chu, Mengdi Lu, Prema R. Menon, David Waltz, Tanya G. Weinstock, L. Zelazoski, Jane C. Davies - American Journal of Respiratory and Critical Care Medicine 2023 cited by 65

  13. Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial

    Authors: Eric W.F.W. Alton, David K Armstrong, Deborah Ashby, Katie J Bayfield, Diana Bilton, Emily V Bloomfield, A. Christopher Boyd, June Brand, Ruaridh Buchan, Roberto Calcedo, Paula Carvelli, Mario Chan, Seng H. Cheng, David Collie, Steve Cunningham, Heather Davidson, Gwyneth Davies, Jane C. Davies, Lee A. Davies, Maria H Dewar, Ann Doherty, Jackie Donovan, Natalie S Dwyer, Hala I Elgmati, Rosanna F Featherstone, Jemyr Gavino, Sabrina Gea‐Sorlí, Duncan M. Geddes, James Sr Gibson, Deborah R. Gill, A P Greening, Uta Griesenbach, David M. Hansell, Katharine Harman, Tracy Higgins, Samantha L. Hodges, Stephen C. Hyde, Laura Hyndman, J. Alastair Innes, Joseph Jacob, Nancy E. Jones, Brian F Keogh, Maria P. Limberis, Paul Lloyd-Evans, Alan Maclean, Michelle C Manvell, Dominique McCormick, Michael McGovern, Gerry McLachlan, Cuixiang Meng, M Angeles Montero, Hazel Milligan, Laura Moyce, Gordon Murray, Andrew G. Nicholson, Tina Osadolor, Javier Parra-Leiton, David J. Porteous, Ian A. Pringle, Emma K Punch, Kamila M Pytel, Alexandra L. Quittner, Gina Rivellini, Clare Saunders, Ronald K. Scheule, Sarah Sheard, Nicholas J. Simmonds, Keith Smith, Stephen N. Smith, Najwa Soussi, Samia Soussi, Emma J Spearing, Barbara Stevenson, Stephanie Jones, Minna Turkkila, Rosa P Ureta, Michael D Waller, Marguerite Y Wasowicz, James M. Wilson, Paul Wolstenholme-Hogg - The Lancet Respiratory Medicine 2015 cited by 424

  14. TheStaphylococcus aureusNetwork Adaptive Platform Trial Protocol: New Tools for an Old Foe

    Authors: Steven Y. C. Tong, Jocelyn Mora, Asha C Bowen, Matthew P. Cheng, Nick Daneman, Anna L. Goodman, George Heriot, Todd C. Lee, Roger Lewis, David Chien Lye, Robert K. Mahar, Julie Marsh, Anna McGlothlin, Zoe McQuilten, Susan C. Morpeth, David L. Paterson, David J. Price, Jason Roberts, James O. Robinson, Sebastiaan J. van Hal, Genevieve Walls, Steve Webb, Lyn Whiteway, Dafna Yahav, Joshua S. Davis, for the Staphylococcus aureus Network Adaptive Platform (SNAP) Study Group, Nick Anagnostou, Sophia Archuleta, Eugene Athan, Lauren Barina, Emma Best, Max Bloomfield, Jennifer Bostock, Carly L. Botheras, Asha C Bowen, Philip N Britton, Hannah J. Burden, Anita J Campbell, Hannah Carter, Matthew P. Cheng, Ka Lip Chew, Russel Lee Ming Chong, Geoffrey W. Coombs, Peter Daley, Nick Daneman, Jane C. Davies, Joshua S. Davis, Yael Dishon, Ravindra Dotel, Adrian Dunlop, Felicity Flack, Katie L. Flanagan, Hong Foo, Nesrin Ghanem‐Zoubi, Stefano Giulieri, Anna L. Goodman, Jennifer Grant, Dan Gregson, Stephen Guy, Amanda Gwee, Erica Hardy, Andrew Henderson, George Heriot, Benjamin P. Howden, Fleur Hudson, Jennie Johnstone, Shirin Kalimuddin, Dana de Kretser, Andrea Lay‐Hoon Kwa, Todd A. Lee, Amy Legg, Roger Lewis, Martin Llewelyn, Thomas Lumley, David Chien Lye, Derek R. MacFadden, Robert K. Mahar, Isabelle Malhamé, Michael Marks, Julie Marsh, Marianne Martinello, Gail Matthews, Colin McArthur, Anna McGlothlin, Genevieve McKew, Brendan McMullan, Zoe McQuilten, Eliza Milliken, Jocelyn Mora, Susan C. Morpeth, Srinivas Murthy, Clare Nourse, Matthew O’Sullivan, David L. Paterson, Mical Paul, Neta Petersiel, Lina Petrella, Sarah Pett, David J. Price, Jason Roberts and 27 more - Clinical Infectious Diseases 2022 cited by 101

  15. A Cell-Free Biosensor for Detecting Quorum Sensing Molecules in P. aeruginosa-Infected Respiratory Samples

    Authors: Ke Yan Wen, Loren Cameron, James Chappell, Kirsten Jensen, David Bell, Richard Kelwick, Margarita Kopniczky, Jane C. Davies, Alain Filloux, Paul S. Freemont - ACS Synthetic Biology 2017 cited by 169

  16. Standards for the care of people with cystic fibrosis; establishing and maintaining health

    Authors: Kevin W Southern, C. Addy, Scott C. Bell, Amanda Bevan, Urzula Borawska, Catherine Brown, Pierre‐Régis Burgel, Brenda Button, Carlo Castellani, A. Chansard, Mark Chilvers, Gwyneth Davies, Jane C. Davies, K. De Boeck, Dimitri Declercq, Michael Doumit, Pavel Dřevı́nek, Isabelle Fajac, Silvia Gärtner, Anna M. Georgiopoulos, Sandra Gursli, Andrea Gramegna, C. Hansen, Martin J. Hug, Elise Lammertyn, Edwina C. Landau, Ross Langley, Nicole Mayer-Hamblett, Anna Middleton, Peter G. Middleton, M. Mielus, Lisa Morrison, À. Munck, Barry J. Plant, M. Ploeger, Dominique Bertrand, Tacjana Pressler, Bradley S. Quon, Thomas Radtke, Zoe L. Saynor, Ilan Shufer, Alan R Smyth, Chris Smith, Silke van Koningsbruggen‐Rietschel - Journal of Cystic Fibrosis 2023 cited by 81

  17. Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study

    Authors: Jane C. Davies, Steve Cunningham, William T. Harris, Allen Lapey, Warren E. Regelmann, Gregory S. Sawicki, Kevin W Southern, Sarah Robertson, Yulia Green, Jon Cooke, Margaret Rosenfeld - The Lancet Respiratory Medicine 2016 cited by 345

  18. Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study

    Authors: Margaret Rosenfeld, Claire Wainwright, Mark Higgins, Linda T. Wang, Charlotte McKee, Daniel Campbell, Simon Tian, Jennifer Schneider, Steve Cunningham, Jane C. Davies, Margaret Rosenfeld, Claire Wainwright, Mark Higgins, Linda T. Wang, Charlotte McKee, Daniel Campbell, Simon Tian, Jennifer Schneider, Steve Cunningham, Jane C. Davies, William T. Harris, Peter J. Mogayzel, Karen McCoy, Carlos Milla, Ronald C. Rubenstein, Seth Walker, Philip Black, Gregory S. Montgomery, Susanna A. McColley, Peter Hiatt, Gregory S. Sawicki, Michael J. Rock, Paul Aurora, Félix Ratjen, Anirban Maitra, Andrew Ives, Erol Gaillard, Paul McNalley, Hiranjan Selvadurai, Philip Robinson - The Lancet Respiratory Medicine 2018 cited by 270

  19. Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials

    Authors: Ahmet Uluer, Gordon MacGregor, Pilar Azevedo, V. Indihar, Claire Keating, Marcus Mall, Edward F. McKone, Bonnie W. Ramsey, Steven M. Rowe, Ronald C. Rubenstein, Jennifer L. Taylor‐Cousar, Elizabeth Tullis, Lael M. Yonker, Chenghao Chu, Anna P. Lam, Nitin Nair, Patrick R. Sosnay, Simon Tian, Fredrick Van Goor, Lakshmi Viswanathan, David Waltz, Linda T. Wang, Yingmei Xi, Joanne Billings, Alex Horsley, Alex Horsley, E.F. Nash, Marleen Bakker, Renske van der Meer, Petrus Merkus, Christof J. Majoor, Karen McCoy, Joanne Billings, Krishna Pancham, James Tolle, Bryon Quick, Ahmet Uluer, Emily DiMango, Adupa Rao, Santiago Reyes, Ross C. Klingsberg, Celeste Barreto, Victor E. Ortega, Donna Beth Willey‐Courand, C. Schwarz, Sivagurunathan Sutharsan, Rainald Fischer, Jane C. Davies, J. Duckers, Alex Horsley, Simon Doe, E.F. Nash, Marleen Bakker, Harry Heijerman, Renske van der Meer, Petrus Merkus, Christof J. Majoor, George M. Solomon, Christian A. Merlo, Jennifer Griffonnet, Joseph M. Pilewski, Jordan Dunitz, Saba Sheikh, Ronald C. Rubenstein, Daniel Rosenbluth, Theodore G. Liou, M.V. Indihar, Krishna Pancham, Lael M. Yonker, Samya Z. Nasr, Jennifer Griffonnet, Cynthia D. Brown, Gregory S. Sawicki, Jennifer Ruddy, Emily DiMango, Bryan Garcia, Andrew T. Braun, Alex H. Gifford, Nighat Mehdi, Maria Tupayachi Ortiz, Raksha Jain, Francisco J. Calimano, Jimmy Johannes, Cori Daines, Jason Fullmer, Joel Mermis, Christopher Barrios, Ngoc P. Ly, Brian Casserly, Stephan Eisenmann, Helge Hebestreit, Alexander Kiefer, Sivagurunathan Sutharsan, Rainald Fischer, Gordon MacGregor, D. Peckham, M.J. Ledson, Eva Van Braeckel, Petrus Merkus, Noel G. McElvaney and 6 more - The Lancet Respiratory Medicine 2023 cited by 64

  20. Cystic fibrosis

    Authors: Marcus Mall, Pierre‐Régis Burgel, Carlo Castellani, Jane C. Davies, Matthias Salathé, Jennifer L. Taylor‐Cousar - Nature Reviews Disease Primers 2024 cited by 168

  21. Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis

    Authors: Kevin W Southern, Carlo Castellani, Elise Lammertyn, Alan R Smyth, Donald R. VanDevanter, Silke van Koningsbruggen‐Rietschel, Jürg Barben, Amanda Bevan, Edwin J. Brokaar, Sarah Collins, Gary Connett, T. Daniels, Jane C. Davies, Dimitri Declercq, Silvia Gärtner, Andrea Gramegna, Naomi Hamilton, Jenny Hauser, N. Kashirskaya, Laurence Kessler, J. Lowdon, Halyna Makukh, Clémence Martin, Lisa Morrison, D. Nazareth, Jacquelien Noordhoek, Ciarán O’Neill, E. Owen, H. Oxley, Karen S. Raraigh, Caroline Raynal, Karen A. Robinson, Jobst Roehmel, Carsten Schwarz, Isabelle Sermet‐Gaudelus, Michal Shteinberg, Ian Sinha, Constance Takawira, Peter van Mourik, Marieke Verkleij, Michael D Waller, Alistair Duff - Journal of Cystic Fibrosis 2022 cited by 69

  22. Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence

    Authors: Jane C. Davies - Paediatric Respiratory Reviews 2002 cited by 298

  23. Pseudomonas aeruginosainfection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches

    Authors: Helena Lund‐Palau, A R Turnbull, Andrew Bush, Emmanuelle Bardin, Loren Cameron, Odel Soren, Natasha Wierre-Gore, Eric W.F.W. Alton, Jacob G. Bundy, Gary Connett, Saul N. Faust, Alain Filloux, Paul S. Freemont, Andy Jones, Valerie Khoo, Sandra Morales, Ronan A. Murphy, Rishi Pabary, A. Simbo, Silke Schelenz, Zoltán Takáts, Jeremy S. Webb, Huw D. Williams, Jane C. Davies - Expert Review of Respiratory Medicine 2016 cited by 170

  24. Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID)

    Authors: Jürg Barben, Carlo Castellani, À. Munck, Jane C. Davies, Karin M. de Winter‐de Groot, Silvia Gärtner, N. Kashirskaya, Barry Linnane, Sarah Mayell, Susanna A. McColley, Chee Y. Ooi, Marijke Proesmans, Clement L. Ren, Danieli B. Salinas, Dorota Sands, Isabelle Sermet‐Gaudelus, Olaf Sommerburg, Kevin W Southern - Journal of Cystic Fibrosis 2020 cited by 121